Unicycive Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Mountain View, CA
UNCY chart
What traders are saying about $UNCY
Latest postsUnicycive Therapeutics, Inc. news
- UNCY Deadline: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders to Contact the Firm for Information About Their Rights
Business Wire ·
- UNCY URGENT DEADLINE: Unicycive Therapeutics, Inc.
GlobeNewswire ·
- Unicycive Therapeutics, Inc. (NASDAQ:UNCY) SHAREHOLDER
GlobeNewswire ·
- Deadline Alert: Unicycive Therapeutics, Inc. Investors Have
GlobeNewswire ·
- UNCY Deadline Alert: Levi & Korsinsky Reminds Unicycive
GlobeNewswire ·
- UNCY Class Action Lawsuit - Robbins LLP Reminds Unicycive Therapeutics, Inc. Investors of the November 2, 2026 Lead Plaintiff Deadline
The Globe and Mail ·
- Unicycive Deadline: UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
PR Newswire ·
- Unicycive Therapeutics, Inc. Estimates – NASDAQ:UNCY
TradingView ·
- What's Next for Unicycive Therapeutics, Inc. Shareholders After 39.1% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
Morningstar ·
- UNCY UPCOMING DEADLINE: SueWallSt Alerts Unicycive Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
AOL.com ·
- Bronstein, Gewirtz & Grossman LLC Urges Unicycive
GlobeNewswire ·
- Press Release Distribution & Media Outreach Platform for PR Agencies
ACCESS Newswire ·
Unicycive Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $675,000 | $951,000 |
| Net income | -$26.6M | -$36.7M | -$30.5M | -$18.1M |
| Diluted EPS | $-1.67 | $-5.65 | $-1.28 | $-1.20 |
| Total assets (year end) | $49.1M | $31.7M | $14.2M | $2.8M |
| Cash and equivalents (year end) | $29.2M | $26.1M | – | $455,000 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Unicycive Therapeutics, Inc.
- Ticker
- UNCY (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Mountain View, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1766140
- Former names
- Unicycive Therapeutics, Inc.
Frequently asked questions
What exchange is Unicycive Therapeutics, Inc. listed on?
Unicycive Therapeutics, Inc. trades on the Nasdaq under the ticker symbol UNCY.
What industry is Unicycive Therapeutics, Inc. in?
Unicycive Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Unicycive Therapeutics, Inc. headquartered?
Unicycive Therapeutics, Inc.'s business address on file with the SEC is in Mountain View, CA.
When does Unicycive Therapeutics, Inc.'s fiscal year end?
Unicycive Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Unicycive Therapeutics, Inc. report?
Unicycive Therapeutics, Inc. reported $675,000 in revenue for calendar year 2023, according to its SEC filings.